ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/07/2025
Voltar para busca
Dado oficial do USPTO
TEVIMBRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
10/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
05/05/2021
Data de registro
20/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2022
Última transação
10/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
CH
Examinador
STEEL, ALYSSA
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BeOne Medicines I GmbH
BeiGene Switzerland GmbH
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
13/11/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/10/2022
FIMP
FINAL DISPOSITION PROCESSED
25/10/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
20/10/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
24/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2022
PUBO
PUBLISHED FOR OPPOSITION
05/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/06/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
31/05/2022
FINA
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/05/2022
ATRV
ATTORNEY REVIEW COMPLETED
29/03/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
28/03/2022
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
22/02/2022
APET
ASSIGNED TO PETITION STAFF
22/02/2022
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
18/02/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
03/02/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
31/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
14/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/10/2021
PUBO
PUBLISHED FOR OPPOSITION
19/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/09/2021
DOCK
ASSIGNED TO EXAMINER
14/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/07/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/07/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
25/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TEVIMBRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.